Dexcom stock holds near its yearly high after Q2 growth
Published on 09/22/2026 at 20:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dexcom Inc. stock (ISIN US2521311074) stood at USD 89.17 on Nasdaq on September 22, 2026, while the company’s latest reported quarter showed revenue of USD 1.31 billion. The shares were 3.7 percent below the 52-week high of USD 92.59 and 64.8 percent above the 52-week low of USD 54.11.
Revenue reaches USD 1.31 billion
Dexcom reported second-quarter 2026 revenue of USD 1.31 billion, an increase of 13.1 percent from the year-earlier period, according to MarketBeat on September 22, 2026. Revenue of USD 1.31 billion also exceeded the cited analyst estimate of USD 1.29 billion by USD 20 million.
The earnings comparison was similarly positive: second-quarter 2026 earnings reached USD 0.70 per share against a consensus estimate of USD 0.61, while the year-earlier figure was USD 0.48 per share, according to MarketBeat. The figures give investors two separate reference points: 13.1 percent year-on-year revenue growth and USD 0.09 of EPS above consensus.
Analyst target rises to USD 102
Truist Securities maintained its Buy rating on September 18, 2026, and raised its Dexcom price target from USD 93 to USD 102, according to Ad-hoc-News. That change represents an increase of USD 9, or 9.7 percent, from the earlier target.
The broader analyst range cited on September 21, 2026, ran from USD 79 to USD 115, with an average target of USD 94.48, according to Ad-hoc-News. The average stood USD 5.31 above the September 22 share price, while the high estimate was USD 25.83 higher, making valuation and execution the key counterweights to the recent growth figures.
Stock remains near the yearly high
Dexcom had a market capitalization of USD 33.65 billion on September 22, 2026, according to the same-day market data cited by MarketBeat. The stock opened at USD 89.17, compared with a 50-day moving average of USD 84.36 and a 200-day moving average of USD 73.39.
The price therefore stood USD 4.81 above its 50-day average and USD 15.78 above its 200-day average on September 22, 2026. That spread places the current quote above both reference levels, while the 52-week range of USD 54.11 to USD 92.59 shows that the stock is trading close to the upper end of its annual band.
Dexcom stock stays below USD 92.59
Dexcom Inc. stock traded at USD 89.17 on Nasdaq as of September 22, 2026. The same date's market capitalization was USD 33.65 billion, and the 52-week range was USD 54.11 to USD 92.59.
Dexcom Inc. stock at a glance
- Company: Dexcom Inc.
- ISIN: US2521311074
- Ticker: DXCM
- Trading venue: Nasdaq
- Price as of September 22, 2026: USD 89.17
- Market capitalization: USD 33.65 billion as of September 22, 2026
- Sector / Industry: Health care / Health care equipment
